Accelerating market access for a maturing medtech industry in APAC
This paper, Accelerating Market Access for a Maturing Medtech Industry in APAC, published in collaboration with IOVIA, the Asia Pacific Medical Technology Association (APACMed), with significant contributions of key executives from the industry, aims to provide the context to this evolving environment, as governments continually strive to improve access to healthcare by fully leveraging the value of health technologies.
The paper shares rich insights into creating market access enabled organisations. Market access can no longer be understood through the narrow lens of pricing and reimbursement, without taking into consideration other elements such as regulatory, supply chain & channels, training & education, stakeholders & KOL management and financing. Thus, market access is defined here as "bringing of products or solutions to the right patient at the right price points in a timely manner through the efficient enablement of registrations, reimbursement, listing, training and supply".